Search results for "Direct"

showing 10 items of 2669 documents

Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients Aged 80 Years and Older.

2021

The effectiveness of direct oral anticoagulants (DOAC) is non-inferior to vitamin K antagonists (VKA) to treat atrial fibrillation and venous thromboembolism (VTE). In this cross-sectional study, we compared older persons taking DOACs to those taking VKAs. We included ambulatory individuals ≥80 years, affiliated to Mutualité Sociale Agricole of Burgundy, who were refunded for a medical prescription in September 2017. The demographic conditions, registered chronic diseases (RCD), and number and types of prescribed drugs were compared in the DOAC group and VKA group. Of the 3190 included individuals, 1279 (40%) were prescribed DOACs and 1911 (60%) VKAs. Individuals taking VKAs were older than…

medicine.medical_specialtyVitamin KDigoxinmedicine.drug_classHealth Toxicology and MutagenesisAdministration Oral030204 cardiovascular system & hematologyVitamin kdirect oral anticoagulantsArticle03 medical and health sciences0302 clinical medicineInternal medicineAtrial FibrillationMedicineHumans030212 general & internal medicineMedical prescriptionAgedAged 80 and overbusiness.industryAnticoagulantanticoagulantPublic Health Environmental and Occupational HealthRFurosemideAnticoagulantsAtrial fibrillationVenous Thromboembolismmedicine.diseaseaged 80 and overvitamin K antagonistsCross-Sectional StudiesHeart failureAmbulatoryMedicineFemalebusinessmedicine.drugInternational journal of environmental research and public health
researchProduct

Antivitamin K Drugs in Stroke Prevention

2014

Among the different subtypes of ischaemic strokes, almost 20 % are of cardiac origin. Different are the causes of cardioembolic stroke, but the most common is the atrial fibrillation, a supraventricular arrhythmia. Appropriate use of antiplatelet drugs and anticoagulants after transient ischaemic attack (TIA) or ischaemic stroke depends on whether the underlying cause is cardioembolic or of presumed arterial origin. Adequate antiplatelet therapy is recommended for secondary prevention after cerebral ischaemia of presumed arterial origin, whether for patients with TIA and ischaemic stroke of cardiac origin, mainly due to atrial fibrillation. Vitamin K antagonists (VKAs) are highly effective …

medicine.medical_specialtyVitamin KSettore MED/09 - Medicina InternaAppropriate useInternal medicinemedicineAnimalsHumanscardiovascular diseasesRandomized Controlled Trials as TopicPharmacologySupraventricular arrhythmiabusiness.industryPatient choiceStandard treatmentAnticoagulantsVKAs Stroke preventionAtrial fibrillationmedicine.diseaseStrokeIschemic Attack TransientStroke preventionCardiologyCerebral ischaemiaCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation InhibitorsDiscovery and development of direct thrombin inhibitorsCurrent Vascular Pharmacology
researchProduct

Histological findings of the internal inguinal ring in patients having indirect inguinal hernia

2009

BACKGROUND: Aiming to deepen the understanding of the factors involved in the genesis of groin hernia, this study is focused on identifying the histological changes within the muscle fibers of the internal inguinal ring in patients having indirect inguinal hernia. METHODS: In eight patients with primary or recurrent bilateral indirect inguinal hernia who underwent a Stoppa open posterior inguinal hernia repair, a tissue specimen from the edge of the internal inguinal ring was biopsied and histologically examined. RESULTS: In all of the tissue samples, remarkable degenerative changes such as fibrohyaline degeneration of the muscle fibers, vascular congestion, and phlogistic infiltration thro…

medicine.medical_specialtyWeaknessGroinbusiness.industryMuscleseducationInguinal CanalHernia InguinalDegeneration (medical)Anatomymedicine.diseaseSurgerySettore MED/18 - Chirurgia GeneraleInguinal herniamedicine.anatomical_structureIndirect inguinal herniaHumansMedicineSphincterSurgeryHerniamedicine.symptombusinessinguinal hernia internal inguinal ringAbdominal surgeryHernia
researchProduct

Poly(adenosine diphosphate-ribose) polymerase in quail oviduct. Changes during estrogen and progesterone induction

1974

Abstract The activities of the following enzymes have been determined in nuclei of quail oviducts in response to exogenous stimulation of the birds with diethylstilbestrol, used as an estrogen analogue and progesterone: DNA dependent DNA polymerase, DNA dependent RNA polymerase I and II and poly(adenosine diphosphate-ribose) [=poly(ADP-Rib)] polymerase. During primary stimulation with the estrogen analogue the activities of the four DNA dependent polymerases increase to about the same degree. Upon withdrawal of the hormones the levels of the enzymes drop to values known from nuclei from unstimulated quail oviducts. The secondary stimulation with the estrogen analogue causes a significant in…

medicine.medical_specialtyanimal structuresDNA polymerasemedicine.drug_classPoly ADP ribose polymeraseRNA polymerase IICoturnixDNA-Directed DNA PolymeraseOviductschemistry.chemical_compoundRNA Polymerase Ibiology.animalInternal medicineGeneticsmedicineRNA polymerase IAnimalsDiethylstilbestrolProgesteronePolymerasebiologyCell DifferentiationAvidinNADMolecular biologyQuailEndocrinologychemistryEstrogenEnzyme Inductionbiology.proteinFemaleRNA Polymerase IIPoly(ADP-ribose) PolymerasesCell DivisionDNANucleic Acids Research
researchProduct

Out-of-pocket costs in gastrointestinal cancer patients: Lack of a perfectly framed problem contributing to financial toxicity

2021

Abstract Fighting cancer is an economically expensive challenge for both health care payers, and the patients and their families and the median costs for cancer care are rapidly increasing in the last decade. Although both direct and indirect costs of medical assistance have been a frequent source of distress and contention, however analysis of the non-medical expenses incurred directly by cancer patients has not received adequate attention. Developing a deeper understanding of so-called "out-of-pocket" costs may be necessary. Out-of-pocket costs for medical care range from 7 % to 11 % of medical costs for all payers. However, the range of out-of-pocket costs shows considerable variability …

medicine.medical_specialtybusiness.industryCancerHematologymedicine.diseaseMedical careDistressIndirect costsCost of IllnessOncologyHealth caremedicineHumansPatient CareGastrointestinal cancerHealth ExpendituresbusinessIntensive care medicineMedical costsPsychosocialhealth care economics and organizationsGastrointestinal NeoplasmsCritical Reviews in Oncology/Hematology
researchProduct

Economic Aspects in the Treatment of Schizophrenia in Italy: Cost Consequences of an Early Long-acting Injectable Anti-Psychotics (lais) Approach

2017

PurposeThe aim of this analysis was to evaluate the economic consequences of a new treatment approach in the treatment of schizophrenia in the Italian setting. In terms of direct costs, in Italy was estimated that the main driver were represented by hospitalization and residential cost (71% of total direct cost per patient), followed by semi-residential services (13%), anti-psychotic and other drugs (8%) and ambulatory services (8).MethodsA probabilistic cost consequence model was developed to estimate the potential cost reductions derived from an early treatment with atypical long-acting injectable anti-psychotics (aLAIs) drugs. A systematic literature review was carried out to identify di…

medicine.medical_specialtybusiness.industryCost consequencesHealth PolicySchizophrenia (object-oriented programming)Public Health Environmental and Occupational Healthmedicine.diseaseCost reductionPsychiatry and Mental healthIndirect costsLong actingSystematic reviewSchizophreniaEnvironmental healthmedicineScenario analysisPsychiatrybusinessEconomic consequencesEuropean Psychiatry
researchProduct

Main Topics

2012

medicine.medical_specialtybusiness.industryGastro-esophageal reflux diseasemedicine.diseaseGastroenterologyNeurologyInternal medicineGERDmedicinePhysical therapyNeurology (clinical)businessEsophageal motilityDirect stimulationEuropean Journal of Neurology
researchProduct

New rules on driver licensing for patients with obstructive sleep apnea: European Union Directive 2014/85/EU

2016

Editorial, no abstract

medicine.medical_specialtybusiness.industryMedicine (all)Cognitive NeuroscienceApplied psychologyAlternative medicineGeneral MedicineDriver licensingCognitive neuroscienceBehavioral neuroscienceDirectivemedicine.diseaseObstructive sleep apnea03 medical and health sciencesBehavioral Neuroscience0302 clinical medicine030228 respiratory systemMedicinemedia_common.cataloged_instanceEuropean unionbusiness030217 neurology & neurosurgerymedia_commonJournal of Sleep Research
researchProduct

The Cost of Non-Alcoholic Steatohepatitis (NASH) in Europe and USA: The GAIN Study

2019

Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver disorders. The progressive form of NAFLD, non-alcoholic steatohepatitis (NASH), leads to cirrhosis in a proportion of patients and so is associated with a substantial socio-economic burden which, coupled with a steadily rising prevalence, is becoming a growing public health challenge. The Global Assessment of the Impact of NASH (GAIN) study is a socioeconomic, prevalence-based burden of illness study across Europe (France, Germany, Italy, Spain and the United Kingdom) and the United States to determine the socio-economic burden of NASH in the real-world. Methods: GAIN was a retrospective, cross-sec…

medicine.medical_specialtybusiness.industryPublic healthFatty liverDiseasemedicine.diseaseIndirect costsQuality of lifeInformed consentFamily medicinemedicineSteatohepatitisbusinessSocioeconomic statusSSRN Electronic Journal
researchProduct

Gesundheitsökonomische Bewertung einer antibiotischen Prophylaxe gegenüber postoperativen Endophthalmitiden

2002

BACKGROUND: Two independent epidemiological studies recently suggested the prophylactic relevance of an intraocular antibiosis against endophthalmitis after cataract surgery. The resulting intervention programme, however, has not only ethical drawbacks, but also has a health economical dimension, which will be focussed in this paper. MATERIAL AND METHODS: A cost analysis is performed to compare the direct costs saved by prevention of endophthalmitis cases and the costs generated by the prophylaxis itself. Furthermore, the clinics' indirect costs due to treatment of unprevented endophthalmitis cases are estimated. RESULTS: The overall gain in direct costs turns out to be about 368 000 Euro p…

medicine.medical_specialtybusiness.industryPublic healthmedicine.diseaseSurgeryOphthalmologyIndirect costsEndophthalmitisIntervention (counseling)EpidemiologyChemoprophylaxisMedicineAntibiotic prophylaxisbusinessRisk assessmentIntensive care medicinehealth care economics and organizationsKlinische Monatsblätter für Augenheilkunde
researchProduct